Robert E. Hoffman - Net Worth and Insider Trading

Robert E. Hoffman Net Worth

The estimated net worth of Robert E. Hoffman is at least $242,903 dollars as of 2026-08-04. Robert E. Hoffman is the SVP, Finance and CFO of Arena Pharmaceuticals Inc and owns about 1,957 shares of Arena Pharmaceuticals Inc (ARNA) stock worth over $195,680. Robert E. Hoffman is the Director of CombiMatrix Corp and owns about 7,409 shares of CombiMatrix Corp (CBMX) stock worth over $46,306. Robert E. Hoffman is also the CFO & SVP, Finance of Heron Therapeutics Inc and owns about 1,280 shares of Heron Therapeutics Inc (HRTX) stock worth over $683. Besides these, Robert E. Hoffman also holds Kintara Therapeutics Inc (KTRA) . Details can be seen in Robert E. Hoffman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert E. Hoffman has not made any transactions after 2022-02-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Robert E. Hoffman

Are these stocks worth buying? — GuruFocus analysis for each holding

- GF

ARNA Arena Pharmaceuticals Inc

81% of holdings · $196K

CBMX CombiMatrix Corp

19% of holdings · $46K

HRTX Heron Therapeutics Inc

0% of holdings · $683

KTRA Kintara Therapeutics Inc

0% of holdings · $234

Robert E. Hoffman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert E. Hoffman owns 12 companies in total, including Kintara Therapeutics Inc (KTRA) , Kura Oncology Inc (KURA) , and Aravive Inc (ARAV) among others .

Click here to see the complete history of Robert E. Hoffman’s form 4 insider trades.

Insider Ownership Summary of Robert E. Hoffman

Ticker	Company	Transaction Date	Type of Owner
KTRA	Kintara Therapeutics Inc	2022-02-15	director & President and CEO
KURA	Kura Oncology Inc	2015-03-17	director
ARAV	Aravive Inc	2019-09-12	director
		2018-07-02	CFO & SVP & Finance
		2017-11-14	director
		2017-05-19	director
		2016-09-06	Chief Financial Officer
		2014-12-15	SVP & Finance and CFO
		2024-01-24	director
		2025-05-15	Chief Financial Officer
		2025-04-01	director
		2025-01-02	director

Robert E. Hoffman Latest Holdings Summary

Robert E. Hoffman currently owns a total of 4 stocks. Among these stocks, Robert E. Hoffman owns 1,957 shares of Arena Pharmaceuticals Inc (ARNA) as of April 1, 2013, with a value of $195,680 and a weighting of 80.56%. Robert E. Hoffman owns 7,409 shares of CombiMatrix Corp (CBMX) as of May 10, 2016, with a value of $46,306 and a weighting of 19.06%. Robert E. Hoffman also owns 1,280 shares of Heron Therapeutics Inc (HRTX) as of July 2, 2018, with a value of $683 and a weighting of 0.28%. The other 1 stocks Kintara Therapeutics Inc (KTRA) have a combined weighting of 0.1% among all his current holdings.

Latest Holdings of Robert E. Hoffman

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ARNA	Arena Pharmaceuticals Inc	2013-04-01	1,957	99.99	195,680
CBMX	CombiMatrix Corp	2016-05-10	7,409	6.25	46,306
HRTX	Heron Therapeutics Inc	2018-07-02	1,280	0.53	683
KTRA	Kintara Therapeutics Inc	2022-02-15	31	7.54	234

Holding Weightings of Robert E. Hoffman

Robert E. Hoffman Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert E. Hoffman has made a total of 0 transactions in Arena Pharmaceuticals Inc (ARNA) over the past 5 years. The most-recent trade in Arena Pharmaceuticals Inc is the sale of 7,125 shares on April 1, 2013, which brought Robert E. Hoffman around $584,962.

According to the SEC Form 4 filings, Robert E. Hoffman has made a total of 0 transactions in CombiMatrix Corp (CBMX) over the past 5 years. The most-recent trade in CombiMatrix Corp is the acquisition of 5,000 shares on May 10, 2016, which cost Robert E. Hoffman around $15,950.

According to the SEC Form 4 filings, Robert E. Hoffman has made a total of 0 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years. The most-recent trade in Heron Therapeutics Inc is the sale of 30,000 shares on July 2, 2018, which brought Robert E. Hoffman around $1 Million.

More details on Robert E. Hoffman's insider transactions can be found in the Insider Trading History of Robert E. Hoffman table.

Insider Trading History of Robert E. Hoffman

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert E. Hoffman Trading Performance

GuruFocus tracks the stock performance after each of Robert E. Hoffman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert E. Hoffman is -23.29%. GuruFocus also compares Robert E. Hoffman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert E. Hoffman within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert E. Hoffman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert E. Hoffman

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-20.48
Relative Return to S&P 500(%)	-18.43

Get the full picture on these stocks

See GF Score, valuation, financials, and warning signs for every stock Robert E. Hoffman owns.

- ARNA - CBMX - HRTX - KTRA

View ARNA Analysis

Robert E. Hoffman Ownership Network

Ownership Network List of Robert E. Hoffman

No Data

Ownership Network Relation of Robert E. Hoffman

Robert E. Hoffman Owned Company Details

What does Kintara Therapeutics Inc do?

Who are the key executives at Kintara Therapeutics Inc?

Robert E. Hoffman is the director & President and CEO of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include Chief Financial Officer Anthony Scott Praill , director & Head of Strategic Partnerships Saiid Zarrabian , and Chief Scientific Officer Dennis M Brown .

Kintara Therapeutics Inc (KTRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kintara Therapeutics Inc Insider Transactions

No Available Data

What does Kura Oncology Inc do?

Who are the key executives at Kura Oncology Inc?

Robert E. Hoffman is the director of Kura Oncology Inc. Other key executives at Kura Oncology Inc include Chief Medical Officer Mollie Leoni , Chief Commercial Officer Brian T. Powl , and Chief Operating Officer Kathleen Ford .

Kura Oncology Inc (KURA) Insider Trades Summary

Over the past 18 months, Robert E. Hoffman made no insider transaction in Kura Oncology Inc (KURA). Other recent insider transactions involving Kura Oncology Inc (KURA) include a net sale of 34,531 shares made by Brian T. Powl , a net sale of 32,632 shares made by Teresa Brophy Bair , and a net sale of 19,422 shares made by Kathleen Ford .

In summary, during the past 3 months, insiders sold 99,781 shares of Kura Oncology Inc (KURA) in total and bought 0 shares, with a net sale of 99,781 shares. During the past 18 months, 318,049 shares of Kura Oncology Inc (KURA) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 218,049 shares.

Kura Oncology Inc (KURA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kura Oncology Inc Insider Transactions

No Available Data

What does Aravive Inc do?

Who are the key executives at Aravive Inc?

Robert E. Hoffman is the director of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .

Aravive Inc (ARAV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aravive Inc Insider Transactions

No Available Data

What does Heron Therapeutics Inc do?

Who are the key executives at Heron Therapeutics Inc?

Robert E. Hoffman is the CFO & SVP & Finance of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include 10 percent owner Rubric Capital Management Lp , other: See Footnote 2 Adam Morgan , and Chief Operating Officer Mark Earl Hensley .

Heron Therapeutics Inc (HRTX) Insider Trades Summary

Over the past 18 months, Robert E. Hoffman made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,387,225 shares made by Rubric Capital Management Lp , and a net purchase of 1,766,546 shares made by Adam Morgan .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 4,153,771 shares were bought by its insiders, resulting in a net purchase of 4,153,771 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Heron Therapeutics Inc Insider Transactions

No Available Data

What does CombiMatrix Corp do?

Who are the key executives at CombiMatrix Corp?

Robert E. Hoffman is the director of CombiMatrix Corp. Other key executives at CombiMatrix Corp include CFO & Secretary & Treasurer Scott R Burell , director & 10 percent owner Martin R Felsenthal , and 10 percent owner Edward L Cahill .

CombiMatrix Corp (CBMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CombiMatrix Corp (CBMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CombiMatrix Corp (CBMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CombiMatrix Corp (CBMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

CombiMatrix Corp Insider Transactions

No Available Data

What does MabVax Therapeutics Holdings Inc do?

Who are the key executives at MabVax Therapeutics Holdings Inc?

Robert E. Hoffman is the director of MabVax Therapeutics Holdings Inc. Other key executives at MabVax Therapeutics Holdings Inc include CHIEF FINANCIAL OFFICER & SECR Gregory P Hanson , EXEC. VP & R AND D Paul W Maffuid , and 10 percent owner David S Wetherell .

MabVax Therapeutics Holdings Inc (MBVXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MabVax Therapeutics Holdings Inc (MBVXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MabVax Therapeutics Holdings Inc (MBVXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MabVax Therapeutics Holdings Inc (MBVXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

MabVax Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Innovus Pharmaceuticals Inc do?

Who are the key executives at Innovus Pharmaceuticals Inc?

Robert E. Hoffman is the Chief Financial Officer of Innovus Pharmaceuticals Inc. Other key executives at Innovus Pharmaceuticals Inc include 10 percent owner Armistice Capital, Llc , 10 percent owner Armistice Capital Master Fund Ltd. , and 10 percent owner Steven Boyd .

Innovus Pharmaceuticals Inc (INNV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Innovus Pharmaceuticals Inc (INNV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovus Pharmaceuticals Inc (INNV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Innovus Pharmaceuticals Inc (INNV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Innovus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Arena Pharmaceuticals Inc do?

Who are the key executives at Arena Pharmaceuticals Inc?

Robert E. Hoffman is the SVP & Finance and CFO of Arena Pharmaceuticals Inc. Other key executives at Arena Pharmaceuticals Inc include director & President and CEO Amit Munshi , EVP & Chief Commercial Officer Robert Lisicki , and Executive VP and CBO Vincent Aurentz .

Arena Pharmaceuticals Inc (ARNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arena Pharmaceuticals Inc Insider Transactions

No Available Data

What does FibroBiologics Inc do?

Who are the key executives at FibroBiologics Inc?

Robert E. Hoffman is the director of FibroBiologics Inc. Other key executives at FibroBiologics Inc include director & Chief Executive Officer Pete O'heeron , Chief Scientific Officer Hamid Khoja , and General Counsel Ruben A Garcia .

FibroBiologics Inc (FBLG) Insider Trades Summary

Over the past 18 months, Robert E. Hoffman made no insider transaction in FibroBiologics Inc (FBLG). Other recent insider transactions involving FibroBiologics Inc (FBLG) include a net purchase of 180,000 shares made by Ruben A Garcia , a net purchase of 50,000 shares made by Hamid Khoja , and a net purchase of 51,500 shares made by Pete O'heeron .

In summary, during the past 3 months, insiders sold 0 shares of FibroBiologics Inc (FBLG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of FibroBiologics Inc (FBLG) were sold and 14,075 shares were bought by its insiders, resulting in a net purchase of 14,075 shares.

FibroBiologics Inc (FBLG)'s detailed insider trading history can be found in Insider Trading Tracker table.

FibroBiologics Inc Insider Transactions

No Available Data

What does CytoDyn Inc do?

Who are the key executives at CytoDyn Inc?

Robert E. Hoffman is the Chief Financial Officer of CytoDyn Inc. Other key executives at CytoDyn Inc include Interim CFO Mitchell Cohen , Interim CEO Jacob P Lalezari , and EVP of Legal Affairs Tyler Blok .

CytoDyn Inc (CYDY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CytoDyn Inc (CYDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoDyn Inc (CYDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CytoDyn Inc (CYDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

CytoDyn Inc Insider Transactions

No Available Data

What does Esperion Therapeutics Inc do?

Who are the key executives at Esperion Therapeutics Inc?

Robert E. Hoffman is the director of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Financial Officer Benjamin Halladay , Chief Operating Officer Sheldon L. Koenig , and General Counsel Benjamin Looker .

Esperion Therapeutics Inc (ESPR) Insider Trades Summary

Over the past 18 months, Robert E. Hoffman made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 42,374 shares made by Benjamin Halladay , a net sale of 40,979 shares made by Benjamin Looker , and a net sale of 199,358 shares made by Sheldon L. Koenig .

In summary, during the past 3 months, insiders sold 76,185 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 76,185 shares. During the past 18 months, 285,491 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 285,491 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Esperion Therapeutics Inc Insider Transactions

No Available Data

What does TuHURA Biosciences Inc do?

Who are the key executives at TuHURA Biosciences Inc?

Robert E. Hoffman is the director of TuHURA Biosciences Inc. Other key executives at TuHURA Biosciences Inc include director & Chief Executive Officer James A. Bianco , Chief Financial Officer Dan Dearborn , and 10 percent owner Vijay Patel .

TuHURA Biosciences Inc (HURA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TuHURA Biosciences Inc (HURA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TuHURA Biosciences Inc (HURA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TuHURA Biosciences Inc (HURA)'s detailed insider trading history can be found in Insider Trading Tracker table.

TuHURA Biosciences Inc Insider Transactions

No Available Data

Robert E. Hoffman Mailing Address

Above is the net worth, insider trading, and ownership report for Robert E. Hoffman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert E. Hoffman's mailing address is: San Diego Ca 92121.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.